Thomson Medical Group Limited (A50.SI)
- Previous Close
0.0510 - Open
0.0510 - Bid 0.0510 x --
- Ask 0.0520 x --
- Day's Range
0.0510 - 0.0520 - 52 Week Range
0.0500 - 0.0660 - Volume
11,500 - Avg. Volume
4,395,465 - Market Cap (intraday)
1.375B - Beta (5Y Monthly) 0.92
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date Feb 2, 2024
- Forward Dividend & Yield 0.00 (0.78%)
- Ex-Dividend Date Oct 24, 2023
- 1y Target Est
0.08
Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore and Malaysia. The company operates in Hospital Services and Specialised Services segments. It owns and operates the Thomson Medical Centre, as well as a network of 39 clinics and centers that provide integrated medical healthcare facilities and services, such as obstetrics, gynaecology, paediatric, diagnostic imaging, pharmacy, 24-hour outpatient, laboratory, health screening, breast and gynaecological oncology, dentistry, musculoskeletal and sports medicine, and medical aesthetics services, as well as counselling and specialised learning services for children with learning difficulties; and services provided by the fertility clinics, paediatric centres, cancer centres, cardiology centres, Chinese medicines, and specialist skin centres. The company also provides consumer products and services. In addition, it operates a pre-natal and clinical diagnostic laboratory; the Thomson Hospital Kota Damansara, a 205-bed hospital located in Kota Damansara, Kuala Lumpur; Thomson Iskandar Medical Hub; 6 fertility centers; and the Vantage Bay Healthcare City located in Iskandar Malaysia. Further, the company provides fertility consultancy, laboratory and embryology, research and development, and property development services. Additionally, it is involved in the information technology and computer service activities; and provision of project related services, including managing vaccination centres, COVID-19 treatment facilities, and transitional care facilities. The company was founded in 1979 and is based in Singapore.
www.thomsonmedical.comRecent News: A50.SI
Performance Overview: A50.SI
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: A50.SI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: A50.SI
Valuation Measures
Market Cap
1.35B
Enterprise Value
2.20B
Trailing P/E
85.00
Forward P/E
51.02
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.97
Price/Book (mrq)
2.77
Enterprise Value/Revenue
6.47
Enterprise Value/EBITDA
23.56
Financial Highlights
Profitability and Income Statement
Profit Margin
4.57%
Return on Assets (ttm)
2.49%
Return on Equity (ttm)
3.79%
Revenue (ttm)
345.39M
Net Income Avi to Common (ttm)
15.78M
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
261.14M
Total Debt/Equity (mrq)
199.10%
Levered Free Cash Flow (ttm)
116.46M
Research Analysis: A50.SI
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: A50.SI
A50.SI does not have Company Insights